Developing clinical nutrition products for patients with special dietary needs
Cancer and its treatments can reduce appetite and make eating or absorbing nutrients difficult. Patients may need extra protein and calories rather than a standard healthy diet. Malnutrition can complicate recovery, and patients who are malnourished before surgery may have trouble healing.
Anutmed Pharma develops and markets clinical nutrition products, including foods for special medical purposes and dietary supplements. Its nutritional solutions are aimed at healthcare professionals supporting patients during recovery.
What stands out about Anutmed Pharma
Grupo Lence announced a completed strategic investment in June 2026.
Co-founder Roberto Conde previously founded Nutrición Médica before helping establish Anutmed Pharma.
Co-founder Roberto Conde held director roles at Novartis and Pfizer in Spain before co-founding Anutmed Pharma.
Get a curated pipeline of healthcare and life sciences startups aligned with your investment thesis.